NeoImmune Investors
NeoImmune is a developer of technologies for the reading and writing of T and B lymphocyte receptor repertoire and its medical applications.
Connections
Industry:
Healthcare Company
Founded Date:
2019
Investor Type:
Healthcare Company
Employee Number:
29
Headquarters:
Shenzhen, Guangdong, China